Bio-Medical Applications Of Alabama in Saraland, Alabama - Dialysis Center

Bio-Medical Applications Of Alabama is a medicare approved dialysis facility center in Saraland, Alabama and it has 13 dialysis stations. It is located in Mobile county at 107 Saraland Loop, Saraland, AL, 36571. You can reach out to the office of Bio-Medical Applications Of Alabama at (251) 679-5590. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Alabama has the following ownership type - Profit. It was first certified by medicare in July, 2017. The medicare id for this facility is 012696 and it accepts patients under medicare ESRD program.

Name	Bio-Medical Applications Of Alabama
Location	107 Saraland Loop, Saraland, Alabama
No. of Dialysis Stations	13
Medicare ID	012696
Managed By	Fresenius Medical Care
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of Alabama from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1861943003
Organization Name	Fresenius Kidney Care Saraland
Doing Business As	Bio-medical Applications Of Alabama, Inc.
Address	107 Saraland Loop Saraland, Alabama, 36571
Phone Number	(251) 679-5590

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	19
  Adult patient months included in Kt/V greater than or equal to 1.2	19
  Percentage of adult patients getting regular hemodialysis at the center	100
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of Alabama with elevated calcium levels.

Patients with hypercalcemia	19
Hypercalcemia patient months	19
Patients with Serumphosphor	19
Patients with Serumphosphor less than 3.5 mg/dL	32
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	26
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	42

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	18
Patient months included in arterial venous fistula and catheter summaries	33
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	76